Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Cogstate Limited (CGS)
  6. Company Financials

Cogstate Limited (ASX: CGS) - Financials

Current share price for CGS : $1.285 0.055 (4.10%)

Cogstate Limited (CGS) is the neuroscience technology company optimising brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Cogstate technologies provide rapid, reliable and highly sensitive computerised cognitive tests across a growing list of domains and support electronic clinical outcome assessment (eCOA) solutions to replace costly and error-prone paper assessments with real-time data capture.

Intelligent Investor free trial for buy hold sell stock recommendations

CGS Per Share

Year to Jun Sales Cashflow Earnings Dividends Franking Book Value Average
Annual P/E		 Relative P/E Shareholder Return
2023 $0.35 0.6 ¢ 3 ¢ 0 ¢ 0% $0.33 56.3 371.8% 8.2%
2022 $0.37 8 ¢ 6.2 ¢ 0 ¢ 0% $0.28 32 193.2% 12.1%
2021 $0.25 12.4 ¢ 2.1 ¢ 0 ¢ 0% $0.17 41.7 353.2% 277.8%

CGS Capital Structure

Total Debt Interest Long Term Debt Percent Debt Preferred Stock Share Equity Percent Equity
$571.50 $105.30 $40.60 0% $0.00 $56,846 100%
Note: All dollars in thousands ('000) for the table above

CGS Historical Financials

2023 2022 2021
Revenue ($M) 61 65.3 43.5
Operating Margin (%) 12.3 29 17.6
Depreciation ($M) -1.3 -1.8 -1.9
Amortisation ($M) -3 -2 -1
Net Profit Before Abs ($M) 5.4 10.9 3.7
Net Profit After Abs ($M) 5.4 10.9 7
Income Tax Rate (%) -17.9 29.7 10.1
Net Profit Margin (%) 8.8 16.7 8.5
Employees ($T) 0.4 0.4
Long Term Debt ($M) 0.9 1.5
Shareholders Equity ($M) 56.8 47.8 29
Return on Capital (%) 10 23 12
Return on Equity (%) 9.5 22.8 12.8
Payout Ratio (%)

CGS Cashflow

2023 2022 2021
Customer Receipts ($M) 60 59 57
Net Operating Cashflow ($M) 0.99 14.12 21.43
Net Investing Cashflow ($M) -3 -5 -3
Net Financing Cashflow ($M) -1 1

CGS Market & Earnings

2023 2022 2021
Market Cap ($M) 286 264 233
Net Gearing (%) -75.1 -88.6 -100.5
Net Interest Cover (%) -3.78 304.88 43.67
Dividend Yield (%)
NTA Per Share ($) 0.23 0.19 0.1
EBITDA ($M) 7.52 18.95 7.65
EBIT ($M) 3.61 15.57 4.6
EBT Before Abs ($M) 4.56 15.52 4.49

CGS Balance Sheet

2023 2022 2021
Cash ($M) 43.3 44.4 31.4
Debtors ($M) 11.36 11.72 10.44
Other Debtors ($M) 0.15 0.35 0.04
Prepayments ($M) 1.89 1.46 0.99
Inventories ($M)
Current Investments ($M)
Other Current Assets ($M) 1.84 3.01 2.4
Total Current Assets ($M) 58.5 61 45.3
Receivables ($M)
Inventories ($M)
Property, Plant & Equipment ($M) 9.01 10.28 10.08
Accumulated Depreciation ($M) -8.11 -7.35 -6.36
Intangibles ex. Goodwill ($M) 16.8 15.6 11.6
Goodwill ($M)
Future Income Tax Benefit ($M) 5.39 5.32 7.71
Non-Current Investments ($M)
Other Non-Current Assets ($M)
Total Non-Current Assets ($M) 23.1 23.9 23
Total Assets ($M) 81.5 84.8 68.3
Accounts Payable ($M) 6.87 14.82 11.63
Provisions ($M) 3.4 3.76 3.26
Short Term Debt ($M) 0.53 1.19 0.81
Other Current Liabilities ($M) 7.56 6.73 9.49
Total Current Liabilities ($M) 18.4 26.5 25.2
Creditors ($M)
Long Term Debt ($M) 0.04 0.86 1.51
Provisions ($M) 1.04 0.9 0.85
Other Non-Current Liabilities ($M) 5.27 8.78 11.83
Total Non-Current Liabilities ($M) 6.35 10.54 14.19
Total Liabilities ($M) 24.7 37.1 39.4
Share Capital ($M) 54.8 52.5 45.3
Reserves ex. Share Premium ($M) 2.31 0.04 -1.92
Share Premium Reserve ($M)
Retained Profits ($M) -0.25 -4.72 -14.37
Other Shareholders Equity ($M)
Convertible Equity ($M)
Outside Equity Interest ($M)
Total Shareholders Equity ($M) 56.8 47.8 29

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.